Cargando…

Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models

Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a se...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung-Eun, Leem, Yea-Hyun, Park, Jin-Sun, Kim, Do-Yeon, Kang, Jihee Lee, Kim, Hee-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026703/
https://www.ncbi.nlm.nih.gov/pubmed/35457238
http://dx.doi.org/10.3390/ijms23084420
_version_ 1784691178900291584
author Park, Jung-Eun
Leem, Yea-Hyun
Park, Jin-Sun
Kim, Do-Yeon
Kang, Jihee Lee
Kim, Hee-Sun
author_facet Park, Jung-Eun
Leem, Yea-Hyun
Park, Jin-Sun
Kim, Do-Yeon
Kang, Jihee Lee
Kim, Hee-Sun
author_sort Park, Jung-Eun
collection PubMed
description Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a selective α7 nicotinic acetylcholine receptor (α7 nAChR) agonist, in neuroinflammation and Parkinson’s disease (PD) mouse models. GTS-21 inhibited the expression of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated BV2 microglial cells and primary microglia. Further research revealed that GTS-21 has anti-inflammatory properties by inhibiting PI3K/Akt, NF-κB, and upregulating AMPK, Nrf2, CREB, and PPARγ signals. The effects of GTS-21 on these pro-/anti-inflammatory signaling molecules were reversed by treatment with an α7 nAChR antagonist, suggesting that the anti-inflammatory effects of GTS-21 are mediated through α7 nAChR activation. The anti-inflammatory and neuroprotective properties of GTS-21 were then confirmed in LPS-induced systemic inflammation and MPTP-induced PD model mice. In LPS-injected mouse brains, GTS-21 reduced microglial activation and production of proinflammatory markers. Furthermore, in the brains of MPTP-injected mice, GTS-21 restored locomotor activity and dopaminergic neuronal cell death while inhibiting microglial activation and pro-inflammatory gene expression. These findings suggest that GTS-21 has therapeutic potential in neuroinflammatory and neurodegenerative diseases such as PD.
format Online
Article
Text
id pubmed-9026703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90267032022-04-23 Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models Park, Jung-Eun Leem, Yea-Hyun Park, Jin-Sun Kim, Do-Yeon Kang, Jihee Lee Kim, Hee-Sun Int J Mol Sci Article Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a selective α7 nicotinic acetylcholine receptor (α7 nAChR) agonist, in neuroinflammation and Parkinson’s disease (PD) mouse models. GTS-21 inhibited the expression of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated BV2 microglial cells and primary microglia. Further research revealed that GTS-21 has anti-inflammatory properties by inhibiting PI3K/Akt, NF-κB, and upregulating AMPK, Nrf2, CREB, and PPARγ signals. The effects of GTS-21 on these pro-/anti-inflammatory signaling molecules were reversed by treatment with an α7 nAChR antagonist, suggesting that the anti-inflammatory effects of GTS-21 are mediated through α7 nAChR activation. The anti-inflammatory and neuroprotective properties of GTS-21 were then confirmed in LPS-induced systemic inflammation and MPTP-induced PD model mice. In LPS-injected mouse brains, GTS-21 reduced microglial activation and production of proinflammatory markers. Furthermore, in the brains of MPTP-injected mice, GTS-21 restored locomotor activity and dopaminergic neuronal cell death while inhibiting microglial activation and pro-inflammatory gene expression. These findings suggest that GTS-21 has therapeutic potential in neuroinflammatory and neurodegenerative diseases such as PD. MDPI 2022-04-16 /pmc/articles/PMC9026703/ /pubmed/35457238 http://dx.doi.org/10.3390/ijms23084420 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Park, Jung-Eun
Leem, Yea-Hyun
Park, Jin-Sun
Kim, Do-Yeon
Kang, Jihee Lee
Kim, Hee-Sun
Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title_full Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title_fullStr Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title_full_unstemmed Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title_short Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
title_sort anti-inflammatory and neuroprotective mechanisms of gts-21, an α7 nicotinic acetylcholine receptor agonist, in neuroinflammation and parkinson’s disease mouse models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026703/
https://www.ncbi.nlm.nih.gov/pubmed/35457238
http://dx.doi.org/10.3390/ijms23084420
work_keys_str_mv AT parkjungeun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels
AT leemyeahyun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels
AT parkjinsun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels
AT kimdoyeon antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels
AT kangjiheelee antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels
AT kimheesun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels